Full-Time
Posted on 9/17/2025
Automated platform for live single-cell assays
$130k - $160k/yr
San Mateo, CA, USA
In Person
Cellanome provides an automated platform for live-cell phenotypic and functional assays that analyze single cells at scale. It runs high-throughput experiments that integrate with existing lab workflows, collecting multi-parameter data and allowing iterative testing under different conditions. The system emphasizes single-cell granularity, scalable data collection, and easy assay customization without major process changes. Its goal is to help life sciences, medical research, pharmaceutical, and biotech teams gain deeper cellular insights to accelerate discovery through a platform-as-a-service model.
Company Size
51-200
Company Stage
Series B
Total Funding
$201M
Headquarters
Foster City, California
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Stock Options
401(k) Retirement Plan
Flexible Work Hours
A Peninsula startup launched by top former Illumina execs raises $150 million to help researchers see what happens when cells dance with each other.
Biotech A-listers have come together to launch a new venture. What's it targeting? They're not saying.